BTI-320, a Nonsystemic Novel Drug to Control Glucose Uptake into the Bloodstream, Functions as a Competitive Inhibitor of Sugar Hydrolyzing EnzymesKevin H. Mayo, Aurelio Dregni,Michelle C. Miller, Ben Rivnay, David PlattDIABETES（2015）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
